CD95 (FAS) Antibody, anti-human, REAlease®
Synonyms: FAS, ALPS1A, APO-1, Apt1, FAS1, FASTM, Tnfrsf6
RECOMBINANT EXTENDED VALIDATION
Clone:
REAL186
Type of antibody:
Releasable antibodies, Primary antibodies, Recombinant antibodies
Applications:
FC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a size:
Other sizes

Related products for CD95 (FAS) Antibody, anti-human, REAlease®

Flow cytometry applications
APC
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-114-954, 130-114-947, 130-122-726
Description:
Splenocytes from C57BL6 mice were stained with REAlease Anti-Ly-49H-FITC (B) or with the corresponding REAL Control (A). REAlease Anti-Ly-49H-FITC was released using the REAlease Release Reagent (C). To show epitope accessibility after REAlease Complex release, the cells were washed with the REAlease Stop Reagent and restained with REAlease Anti-Ly-49H-FITC (D). Cells were labeled with CD49b antibodies in addition and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide (PI) fluorescence.

Application imageView details view details

Application imageView details view details

Application imageView details view details

Application imageView details view details
MICS (MACSima Imaging Cyclic Staining) applications
APC
Fixation:
frozen – Acetone
Species tested:
human
Tissue used:
tonsil
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-114-954, 130-114-947
Testing grade:
Description:
Immunofluorescence analysis of a human tonsil cryosection fixed with ice-cold acetone. The section was stained using CD95 (FAS) Antibody, anti-human, APC (green) for 10 min at room temperature (A). CD95 (FAS) Antibody, anti-human, APC staining was released using the REAlease Release Reagent (B). Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm.

A

Application imageView details view details

B

Application imageView details view details
Extended validation for CD95 (FAS) Antibody, anti-human, REAlease®
Specificity
Knockout validation

To ensure antibody specificity, the target gene is knocked out in a suitable cell line using the CRISPR/Cas9 system and the knockout is confirmed by sequencing of the target locus. The antibody is considered to bind specifically to the intended epitope if no antibody binding to the knockout cells can be detected. The antibody staining is controlled by fluorescence microscopy and/or flow cytometry.

Extended-Validation detailed information image

Overlay histogram showing flow cytometric analysis of CD95 knockout cells. Wild type (red) and knockout cells (blue) were stained with CD95-APC, clone (REAL186). Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells and cell doublets were excluded from the analysis based on scatter signals and propidium iodide fluorescence.

Specifications for CD95 (FAS) Antibody, anti-human, REAlease®
Overview

Clone REAL186 is an antibody fragment derived from the full CD95 (FAS) antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity.

Clone REAL186 recognizes the human CD95 antigen, also known as FAS and Apo-1, which is a member of the tumor necrosis factor receptor superfamily (TNFR). CD95 is found on the surface of many normal and neoplastically transformed cells. Its ligand, CD95L (FASL/Apo-1L), is able to induce apoptosis in CD95-expressing cells upon binding. CD95 and CD95L are upregulated on lymphocytes upon activation and are known to play a key role in the regulation of an inflammatory response: Juxtocrine “fratricide” of neighbouring lymphocytes via mutual CD95 and CD95L expression helps to terminate immune responses, while apoptosis of pro-inflammatory cells via CD95 helps maintain immune privilege in sites such as the eye, where CD95L is found to be expressed in the retina and cornea.

The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.

Alternative names

FAS, ALPS1A, APO-1, Apt1, FAS1, FASTM, Tnfrsf6

Detailed product information

Technical specifications

Clone
REAL186
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable antibodies, Primary antibodies, Recombinant antibodies
Species reactivity
human
Antigen
CD95 (FAS)
Distribution of antigen
lymphocytes
RRID
AB_2784324, AB_2751242, AB_2751243
Resources for CD95 (FAS) Antibody, anti-human, REAlease®
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD95 (FAS) Antibody, anti-human, REAlease®
Publications
  1. Pitcher, C. J. et al. (2002) Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168: 29-43
  2. Griffith, T. et al. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192
  3. Lynch, D. et al. (1995) Fas and FasL in the homeostatic regulation of immune responses. Immunol. Today 16: 569-574